Albu Adriana, Para Ioana, Porojan Mihai
2nd Department of Internal Medicine.
4th Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Ther Clin Risk Manag. 2020 Jan 28;16:39-54. doi: 10.2147/TCRM.S232033. eCollection 2020.
Hyperuricemia is usually associated with hypertension, diabetes mellitus, metabolic syndrome and chronic kidney disease. Accumulating data from epidemiological studies indicate an association of increased uric acid (UA) with cardiovascular diseases. Possible pathogenic mechanisms include enhancement of oxidative stress and systemic inflammation caused by hyperuricemia. Arterial stiffness may be one of the possible pathways between hyperuricemia and cardiovascular disease, but a clear relationship between increased UA and vascular alterations has not been confirmed. The review summarizes the epidemiological studies investigating the relationship between UA and arterial stiffness and highlights the results of interventional studies evaluating arterial stiffness parameters in patients treated with UA-lowering drugs.
高尿酸血症通常与高血压、糖尿病、代谢综合征及慢性肾脏病相关。来自流行病学研究的越来越多的数据表明,尿酸(UA)升高与心血管疾病之间存在关联。可能的致病机制包括高尿酸血症引起的氧化应激增强和全身炎症。动脉僵硬度可能是高尿酸血症与心血管疾病之间的可能途径之一,但尿酸升高与血管改变之间的明确关系尚未得到证实。本综述总结了调查尿酸与动脉僵硬度之间关系的流行病学研究,并突出了评估使用降尿酸药物治疗的患者动脉僵硬度参数的干预性研究结果。